TTM
$8.07
YoY change
+4.7%
5Y CAGR
+40.5%
Peak year (2025)
$7.84
Latest annual
$7.84
EPS (Diluted) history chart for IQVIA (IQV) from 2010 to 2025
Latest: $7.84
EPS (Diluted) growth chart for IQVIA (IQV) from 2010 to 2025
Latest: +4.7%
EPS (Diluted) history table for IQVIA (IQV) from 2010 to 2025
| 2025 | $7.84 | +4.7% | +$0.35 | ||
| 2024 | $7.49 | +2.7% | +$0.20 | ||
| 2023 | $7.29 | +27.4% | +$1.57 | ||
| 2022 | $5.72 | +15.6% | +$0.77 | ||
| 2021 | $4.95 | +246.2% | +$3.52 | ||
| 2020 | $1.43 | +49.0% | +$0.47 | ||
| 2019 | $0.96 | -22.6% | −$0.28 | ||
| 2018 | $1.24 | -78.9% | −$4.64 | ||
| 2017 | $5.88 | +673.7% | +$5.12 | ||
| 2016 | $0.76 | -75.3% | −$2.32 | ||
| 2015 | $3.08 | +13.2% | +$0.36 | ||
| 2014 | $2.72 | +53.7% | +$0.95 | ||
| 2013 | $1.77 | +27.3% | +$0.38 | ||
| 2012 | $1.39 | -26.8% | −$0.51 | ||
| 2011 | $1.90 | +50.8% | +$0.64 | ||
| 2010 | $1.26 | — | — |
- 2025$7.84+4.7%
- 2024$7.49+2.7%
- 2023$7.29+27.4%
- 2022$5.72+15.6%
- 2021$4.95+246.2%
- 2020$1.43+49.0%
- 2019$0.96-22.6%
- 2018$1.24-78.9%
- 2017$5.88+673.7%
- 2016$0.76-75.3%
- 2015$3.08+13.2%
- 2014$2.72+53.7%
- 2013$1.77+27.3%
- 2012$1.39-26.8%
- 2011$1.90+50.8%
- 2010$1.26—
EPS (Diluted) values are taken from IQVIA's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at IQVIA (IQV)
According to IQVIA's latest reported financial statements, the company's current diluted EPS (TTM) is $8.07. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, IQVIA (IQV) diluted EPS totalled $7.84 – edged up 4.7% year-over-year.
Over 2020–2025 (5 years), IQVIA diluted EPS expanded at a +40.5% compound annual rate, sustaining 6 straight years of year-over-year growth.
The record annual diluted EPS stands at $7.84, reached in 2025; the historical low of $0.76 was recorded in 2016.
IQVIA EPS (Diluted) by Year
IQVIA EPS (Diluted) 2025: $7.84
2025's diluted EPS for IQVIA came in at $7.84, edged up 4.7% from 2024. This figure represents the highest annual value in the available history.
IQVIA EPS (Diluted) 2024: $7.49
IQVIA posted diluted EPS of $7.49 in 2024, edged up 2.7% from 2023.
IQVIA EPS (Diluted) 2023: $7.29
In 2023, IQVIA reported diluted EPS of $7.29, grew 27.4% from 2022.
IQVIA EPS (Diluted) 2022: $5.72
IQVIA diluted EPS in 2022 was $5.72, grew 15.6% from 2021.
IQVIA EPS (Diluted) 2021: $4.95
IQVIA diluted EPS in 2021 was $4.95.
See more financial history for IQVIA (IQV). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of IQVIA (IQV), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
IQVIA (IQV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation